Literature DB >> 2832177

Inter-experiment variation and dependence on culture conditions in assaying the chemosensitivity of human small cell lung cancer cell lines.

H Roed1, I B Christensen, L L Vindeløv, M Spang-Thomsen, H H Hansen.   

Abstract

Sensitivity of five human small cell lung cancer cell lines to doxorubicin was assessed by a double layer agar technique using two different bottom-layers. Neither of the bottom-layers provided proportionality between numbers of cells plated and numbers of colonies, but they were correlated by a logarithmic function. Even after correction for lack of proportionality the two assay systems provided significantly different dose-response curves. The stability of the chemosensitivity was tested after 25-30 weeks continuous in vitro culture or prolonged storage in liquid nitrogen. One cell line underwent significant changes after continuous in vitro culture whereas the cell lines tested after prolonged storage in liquid nitrogen showed only minor changes. It is concluded that instead of considering the concentration necessary to achieve a certain degree of cell kill (e.g. ID50) in one experiment on one cell line, dose-response curves obtained on several cell lines in different assay systems should be used in the evaluation of new drugs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2832177     DOI: 10.1016/0277-5379(87)90012-5

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  13 in total

1.  Reduced variation in the clonogenic assay obtained by standardization of the cell culture conditions prior to drug testing on human small cell lung cancer cell lines.

Authors:  P B Jensen; H Roed; L Vindeløv; I J Christensen; H H Hansen
Journal:  Invest New Drugs       Date:  1989-11       Impact factor: 3.850

2.  In vitro evaluation of a new nitrosourea, TCNU, against human small cell lung cancer cell lines.

Authors:  H Roed; L L Vindeløv; M Spang-Thomsen; I J Christensen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumor.

Authors:  E Friche; P B Jensen; N I Nissen
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung.

Authors:  H Roed; L L Vindelov; I J Christensen; M Spang-Thomsen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity.

Authors:  P B Jensen; H Roed; M Sehested; E J Demant; L Vindeløv; I J Christensen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Postincubation with aclarubicin reverses topoisomerase II mediated DNA cleavage, strand breaks, and cytotoxicity induced by VP-16.

Authors:  L N Petersen; P B Jensen; B S Sørensen; S A Engelholm; M Spang-Thomsen
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

7.  In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL).

Authors:  P B Jensen; L Vindeløv; H Roed; E J Demant; M Sehested; T Skovsgaard; H H Hansen
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

8.  Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulators.

Authors:  M Sehested; P B Jensen; T Skovsgaard; N Bindslev; E J Demant; E Friche; L Vindeløv
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

9.  Low-level resistance to camptothecin in a human small-cell lung cancer cell line without reduction in DNA topoisomerase I or drug-induced cleavable complex formation.

Authors:  M Sorensen; M Sehested; I J Christensen; J K Larsen; P B Jensen
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

10.  Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.

Authors:  M Sehested; T Skovsgaard; P B Jensen; E J Demant; E Friche; N Bindslev
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.